| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 6.709 | 11.929 | 33.084 | 37.721 | 45.718 | 43.038 | 42.998 | 54.943 | 71.965 | 71.901 |
| Total Income - EUR | 6.709 | 11.930 | 33.084 | 37.721 | 45.718 | 43.492 | 42.999 | 55.207 | 71.971 | 71.935 |
| Total Expenses - EUR | 9.125 | 13.272 | 18.080 | 24.927 | 31.845 | 25.900 | 31.800 | 39.806 | 46.630 | 54.125 |
| Gross Profit/Loss - EUR | -2.416 | -1.343 | 15.004 | 12.793 | 13.873 | 17.592 | 11.198 | 15.401 | 25.341 | 17.810 |
| Net Profit/Loss - EUR | -2.617 | -1.606 | 14.677 | 12.412 | 13.416 | 17.302 | 11.049 | 14.931 | 24.636 | 15.695 |
| Employees | 1 | 2 | 0 | 3 | 2 | 3 | 3 | 3 | 3 | 2 |
Check the financial reports for the company - Alma Iuvamed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 1.297 | 2.725 | 8.560 | 5.863 | 4.118 | 1.796 |
| Current Assets | 1.367 | 2.490 | 9.898 | 22.464 | 21.510 | 17.054 | 7.522 | 13.706 | 24.324 | 19.070 |
| Inventories | 0 | 0 | 0 | 406 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 313 | 304 | 297 | 1.588 | 3.486 | 2.998 | 1.688 | 3.961 | 16.274 | 2.079 |
| Cash | 1.054 | 2.187 | 9.602 | 20.470 | 18.024 | 14.057 | 5.834 | 9.746 | 8.050 | 16.991 |
| Shareholders Funds | -5.022 | -6.577 | 8.212 | 20.473 | 20.183 | 17.517 | 11.097 | 17.401 | 24.684 | 15.744 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 6.389 | 9.067 | 1.687 | 1.991 | 2.623 | 2.263 | 4.985 | 2.169 | 3.758 | 5.122 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Alma Iuvamed S.r.l.